معرفی
Dr. Keith Oldroyd is an Honorary Professor at the University of Glasgow's School of Cardiovascular & Metabolic Health. His research focuses on coronary physiology, myocardial infarction, and interventional cardiology, with a particular emphasis on fractional flow reserve (FFR) and coronary microvascular dysfunction. He leads major clinical trials such as CorMicA and FAMOUS-NSTEMI, assessing diagnostic and therapeutic strategies in coronary artery disease.
Key contributions include advancing understanding of coronary microvascular dysfunction, optimizing PCI outcomes, and evaluating the clinical impact of influenza vaccination post-MI. Collaborations with institutions globally highlight interdisciplinary work in drug-eluting stents, biomaterials, and cardiovascular imaging.
- Over 150 peer-reviewed publications (2001–2024)
- Principal Investigator for CorMicA trial
- Leadership in Glasgow PRAMI and EVOLVE 48 studies
Labs/Teams: Active in translational cardiology research at the Golden Jubilee National Hospital and University of Glasgow's cardiovascular imaging and intervention teams.